ZYDUS LIFESCIENCES
Back to Balance Sheet
|
ZYDUS LIFESCIENCES Last 5 Year Total Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹9,042 Cr | ₹5,340 Cr | ₹5,527 Cr | ₹7,827 Cr | ₹7,861 Cr |
What is the latest Total Current Liabilities ratio of ZYDUS LIFESCIENCES ?
| Year | Total Current Liabilities |
|---|---|
| Mar2025 | ₹9,042 Cr |
| Mar2024 | ₹5,340 Cr |
| Mar2023 | ₹5,527 Cr |
| Mar2022 | ₹7,827 Cr |
| Mar2021 | ₹7,861 Cr |
How is Total Current Liabilities of ZYDUS LIFESCIENCES Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹9,042 Cr | 69.33 | |
| Mar2024 | ₹5,340 Cr | -3.38 | |
| Mar2023 | ₹5,527 Cr | -29.39 | |
| Mar2022 | ₹7,827 Cr | -0.44 | |
| Mar2021 | ₹7,861 Cr | - | |
Compare Total Current Liabilities of peers of ZYDUS LIFESCIENCES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ZYDUS LIFESCIENCES | ₹92,862.2 Cr | 2.9% | 4% | 4.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹434,999.0 Cr | 3.6% | 7% | 15.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹169,139.0 Cr | 1.1% | 5.8% | 14.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹149,791.0 Cr | 1.9% | 12.3% | 49.2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹109,664.0 Cr | 1.8% | 5.9% | 14.8% | Stock Analytics | |
| CIPLA | ₹107,685.0 Cr | 1.6% | 0.2% | -5.4% | Stock Analytics | |
ZYDUS LIFESCIENCES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ZYDUS LIFESCIENCES | 2.9% |
4% |
4.2% |
| SENSEX | -2.5% |
-6.1% |
7% |
You may also like the below Video Courses